BDA MC still only 14.1mill at these levels/ 11.85mill EV - still by far the cheapest MM listed play on the ASX
Things to look forward to in the coming weeks/months:
1) Continued strength as the market digests the recent granted importation licence through the TGA and NSW Dept Health
2) Medicinal cannabis product formulation using Linnea's standardized cannabis extract to commence. Further updates regarding phase 1 trials to be announced.
3) Further updates re opportunities to cultivate and grow cannabis utilising Linnea’s expertise
3) Continued growth in the company's natural medicines and skincare products following a 180% surge in revenues last quarter and subsequent roll-out of pregnancy supplement distribution. One element from the latest preso that sparked my interest was the reference to "international expansion with key Daigou relationships"... considering the way that other Daigou plays have moved in the last few weeks, I wouldn't be surprised if an update on this puts a rocket under the SP
GLTA holders, hopefully an exciting week ahead!
BDA Price at posting:
40.0¢ Sentiment: Buy Disclosure: Held
